GlassScriptPhysician profile
Ben V Neth
NPI 1942745930
$1,381.01
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $562 · 2022: $725 · 2023: $93.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $93.15.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $93.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $609.45 | 2021-2023 | |
| Novo Nordisk INC | $140.86 | 2021-2023 | |
| Esperion Therapeutics, INC. | $89.96 | 2021-2022 | |
| Lilly USA, LLC | $83.01 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $78.03 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $68.85 | 2022 | |
| Azurity Pharmaceuticals, INC. | $57.33 | 2022 | |
| Currax Pharmaceuticals LLC | $57.26 | 2021-2022 | |
| Ethicon US, LLC | $33.39 | 2021 | |
| Amgen INC. | $27.78 | 2023 | Repatha, Otezla |
| Exact Sciences Corporation | $24.96 | 2023 | Cologuard Collection Kit |
| Axsome Therapeutics, INC. | $23.44 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $21.22 | 2022 | |
| Sanofi-Aventis U.S. LLC | $18.56 | 2022 | |
| Hologic Sales and Service, LLC | $18.56 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $15.08 | 2021 | |
| Amarin Pharma, INC. | $11.73 | 2021 | |
| Genentech USA, INC. | $1.54 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ben Neth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.